Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.

Welch HG, Woloshin S, Schwartz LM.

J Natl Cancer Inst. 2008 Feb 20;100(4):228-9. doi: 10.1093/jnci/djn013. Epub 2008 Feb 12. No abstract available.

PMID:
18270336
2.

The case for breast cancer screening in Singapore.

Wee SB.

Singapore Med J. 2002 May;43(5):221-3. No abstract available.

PMID:
12188070
3.

MRI screening in a clinic population with a family history of breast cancer.

Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA.

Ann Surg Oncol. 2008 Feb;15(2):452-61. Epub 2007 Nov 17.

PMID:
18026801
4.

Diagnostic drift in the reporting of cancer incidence.

Bailar JC 3rd.

J Natl Cancer Inst. 1998 Jun 3;90(11):863-4. No abstract available.

PMID:
9625178
5.

NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).

Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R.

NIH Consens State Sci Statements. 2009 Sep 24;26(2):1-27.

6.

Update on atypical epithelial hyperplasia and ductal carcinoma in situ.

Simpson JF.

Pathology. 2009 Jan;41(1):36-9. doi: 10.1080/00313020802568097. Review.

PMID:
19089738
7.

The certainties and the uncertainties of ductal carcinoma in situ.

Morrow M.

J Natl Cancer Inst. 2004 Mar 17;96(6):424-5. No abstract available.

PMID:
15026460
8.

Ductal carcinoma in situ of the breast.

Kettritz U.

N Engl J Med. 2004 Jul 22;351(4):399-402; author reply 399-402. No abstract available.

PMID:
15278957
9.

Management of nonpalpable breast carcinoma discovered by mammography.

Barker WF, Sperling L, Dowdy AH, Zeldis LJ, Longmire WP Jr.

Ann Surg. 1969 Sep;170(3):385-95. No abstract available.

10.

[A practice guideline for diagnosis and treatment of ductal in situ carcinoma of the breast].

Delaloye JF, Wight E, Fink D, Otto R, Steiner R; Groupe de travail coordonné par la Fédération des Médecins Suisses..

Gynakol Geburtshilfliche Rundsch. 2006;46(1-2):64-7. French. No abstract available.

PMID:
16452823
11.

[Nonpalpable breast cancer].

Pushkarev SV, Dikovich MF, Adamian AT, Slonimskaia EM, Zobnina MN.

Vopr Onkol. 1992;38(1):111-3. Russian. No abstract available.

PMID:
1338662
12.
13.

Part I. Epidemiology of ductal carcinoma in situ.

Rakovitch E.

Curr Probl Cancer. 2000 May-Jun;24(3):100-11. Review. No abstract available.

PMID:
10919313
14.

Nonpalpable breast cancer.

Bunnell DH, Bassett LW, Eggerding F, Steckel R.

Am Fam Physician. 1987 May;35(5):147-51.

PMID:
3034014
15.
16.

[Bilateral adenoma of nipple (author's transl)].

Citoler P, Broer KH, Zippel HH.

Geburtshilfe Frauenheilkd. 1973 Sep;33(9):729-31. German. No abstract available.

PMID:
4358421
17.

[Breast cancer in a family].

Wobbes T.

Ned Tijdschr Geneeskd. 1985 Nov 16;129(46):2193-5. Dutch. No abstract available.

PMID:
3001541
18.

[Suspected non-palpable changes in the breast diagnosed by mammography. Treatment planning and therapeutical problems].

Kåresen R, Eliassen G, Natvig NL, Sager EM.

Tidsskr Nor Laegeforen. 1982 Jun 20;102(17-18):960-4. Norwegian. No abstract available.

PMID:
6297119
19.

[The treatment of ductal carcinoma in situ (DCIS) of the breast].

Brandts F.

Ned Tijdschr Geneeskd. 2004 Mar 6;148(10):505; author reply 505. Dutch. No abstract available.

PMID:
15042902
20.

Thermogram and mammogram.

Wasserman NF.

Minn Med. 1974 Dec;57(12):971-4. No abstract available.

PMID:
4371256

Supplemental Content

Support Center